Corrects company ticker symbol in first bullet and header field
** Shares of investment management co Challenger CGF.AX drop as much as 8.8% to A$5.59, their lowest levels since January 28, 2022
** Co posts HY normalised NPAT of A$225 million ($142.94 million), lower than consensus estimate of A$229 million, according to Jefferies
** Total sales for co's core Life segment fall 12% in HY; Life normalised EBIT misses expectations
** Declares interim dividend of 14.5 Australian cents per share, higher than consensus estimates of 13.8 cents
** CGF stock is worst performer on ASX 200 benchmark index .AXJO
** Stock down 4.7% YTD, including day's moves
($1 = 1.5741 Australian dollars)
(Reporting by Himanshi Akhand in Bengaluru)
((Himanshi.Akhand@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.